BackPharvaris NV Overview

Pharvaris NV Total Revenue

Track Pharvaris NV's total revenue ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

N/A

As of Jun 2026

Annual Revenue (TTM)

N/A

Trailing 12 months ending Jun 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Pharvaris NV (PHVS) FAQ

Pharvaris NV (PHVS) currently reports a total revenue of $0 as of June 2026. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Pharvaris NV's total revenue history and peer comparisons.

Pharvaris NV's total revenue changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pharvaris NV's total revenue of $0 is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Pharvaris NV reported $0 in total revenue as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Pharvaris NV, and consider following PHVS for alerts when major investors trade the stock.